“A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of long-Acting Injectable Formulation of Vanoxerine (Vanoxerine Consta 394.2 mg) for Treatment of Amphetamine-Type Stimulant (ATS) Dependence” (2024) London Journal of Medical and Health Research, 24(6), pp. 63–87. Available at: https://journalspress.uk/index.php/LJMHR/article/view/920 (Accessed: 2 February 2026).